You are here: Industry Insights > Arctic Vision

News List

Arctic Vision Joins Forces with the University of Hong Kong, S.A.R., China Department of Ophthalmology to Discover and Develop Novel Neuroprotective Therapies for Ocular Disease firstwordpharma
July 05, 2021
Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today a new research collaboration with Prof.
Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries prnasia
June 07, 2021
Arctic Vision, a clinical stage biotech company focusing on innovative ophthalmology therapies for pan-ocular diseases, and Olympic Ophthalmics, a U.S.-based medical technology company pioneering neuromodulation treatments for ophthalmic diseases ...
Arctic Vision announces exclusive licensing agreement with ActualEyes prnasia
May 17, 2021
Arctic Vision, a clinical stage biotech company focused on innovative ophthalmology therapies for pan-ocular diseases, and ActualEyes, a clinical stage Japanese biotech company committed to the research and development of cell therapy for corneal ...
Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization prnasia
March 10, 2021
Arctic Vision, a China-based clinical-stage ophthalmology company focused on developing innovative therapies for pan-ocular diseases, today announced the completion of over US$100 million Series B financing.
Arctic Vision obtains the first IND approval for the treatment of UME in China, Suprachoroidal space (SCS) injection potentially brings more benefits to patients prnasia
December 28, 2020
Arctic Vision, a China-based clinical-stage ophthalmology company with a leading portfolio of breakthrough technologies, announced on December 24th the clearance of the Investigational New Drug (IND) for Phase III trial of ARVN001 (triamcinolone ...
Arctic Vision Announces US$32MN in Series A to Expand and Develop Innovative Therapies Pipeline in Ophthalmology prnasia
July 14, 2020
Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its $32mn Series A financing led by Morningside Ventures, together with its existing investors.